Reply by Authors.
The Journal of urology, cilt.206, ss.914-922, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 206
- Basım Tarihi: 2021
- Doi Numarası: 10.1097/ju.0000000000001841.03
- Dergi Adı: The Journal of urology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, BIOSIS, CAB Abstracts, EMBASE, Gender Studies Database, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.914-922
- Anahtar Kelimeler: apalutamide, quality of life, prostatic neoplasms, neoplasm metastasis, CHEMOTHERAPY-NAIVE PATIENTS, ABIRATERONE ACETATE, DOUBLE-BLIND, PREDNISONE, PATIENT, MEN
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır
Özet
Purpose: We performed an exploratory analysis of prostate cancer-related pain and fatigue on health-related quality of life in patients with metastatic castration-sensitive prostate cancer receiving apalutamide (240 mg/day) or placebo, with continuous androgen deprivation therapy (ADT), in the phase 3, randomized, double-blind, placebo controlled TITAN trial (NCT02489318).